The impact of high-risk patients on the results of clinical trials
- 1 October 1997
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 50 (10) , 1089-1098
- https://doi.org/10.1016/s0895-4356(97)00149-2
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia populationThe Lancet, 1996
- Viral Counts Count in HIV InfectionScience, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infectionNature Medicine, 1996
- Predictive value of viral load measurements in asymptomatic untreated HIV-1 infectionAIDS, 1996
- Staging system for clinical AIDS patientsThe Lancet, 1995
- Can overall results of clinical trials be applied to all patients?The Lancet, 1995
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995
- Generalizing the results of randomized clinical trialsControlled Clinical Trials, 1994